Home
Events
Jobs
About
Members
Contact Us
Emtora Biosciences Turns Sights on Rare Genetic Disease, New Funding
May 7, 2019
by
Website Admin
in
Tweet
Share
Pin it
Previous Story
Forbius’ AVID200, a Novel TGF-beta 1 & 3 Inhibitor, Cleared by Health Canada to Commence Phase 1 Clinical Trial in Solid Tumors
Next Story
Lexicon Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides a Business Update
Top